-
1
-
-
33847223412
-
Bellas) A y cols. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
-
Block GA, Raggi P, Bellas) A y cols. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007.
-
(2007)
Kidney Int
-
-
Block, G.A.1
Raggi, P.2
-
2
-
-
0034836578
-
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients
-
Ganesh SK, Stack AG, Levin NW y cols. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12:2131-2138.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 2131-2138
-
-
Ganesh, S.K.1
Stack, A.G.2
Levin, N.W.3
-
3
-
-
3042528668
-
Arterial calcifications and bone histomorphometry in end-stage renal disease
-
London GM, Marty C, Marchais SJ y cols. Arterial calcifications and bone histomorphometry in end-stage renal disease. JAm Soc Nephrol 2004; 15: 1943-1951.
-
(2004)
JAm Soc Nephrol
, vol.15
, pp. 1943-1951
-
-
London, G.M.1
Marty, C.2
Marchais, S.J.3
-
4
-
-
1542347890
-
Vascular calcification in chronic kidney disease
-
Goodman WG, London G, Amann K y cols. Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004; 43: 572-579.
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 572-579
-
-
Goodman, W.G.1
London, G.2
Amann, K.3
-
5
-
-
33645757920
-
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
-
Moe S, Drueke T, Cunningham J y cols. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953.
-
(2006)
Kidney Int
, vol.69
, pp. 1945-1953
-
-
Moe, S.1
Drueke, T.2
Cunningham, J.3
-
6
-
-
0033983570
-
Race is a major determinant of secondary hyperparathyroidism in uremic patients
-
Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 2000; 11: 330-334.
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 330-334
-
-
Gupta, A.1
Kallenbach, L.R.2
Zasuwa, G.3
Divine, G.W.4
-
7
-
-
85047697721
-
Adynamic bone disease with negative aluminium staining in predialysis patients: Prevalence and evolution after maintenance dialysis
-
Hernández D, Concepcion MT, Lorenzo V y cols. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis. Nephrol Dial Transplant 1994; 9: 517-523.
-
(1994)
Nephrol Dial Transplant
, vol.9
, pp. 517-523
-
-
Hernández, D.1
Concepcion, M.T.2
Lorenzo, V.3
-
8
-
-
0035020803
-
Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study
-
Malbertl F, Marcelli D, Conte F y cols. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 2001; 12: 1242-1248.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1242-1248
-
-
Malbertl, F.1
Marcelli, D.2
Conte, F.3
-
9
-
-
0027178439
-
The spectrum of bone disease in end-stage renal failure -an evolving disorder
-
Sherrard DJ, Hercz G, Pei Y y cols. The spectrum of bone disease in end-stage renal failure -an evolving disorder. Kidney Int 1993; 43: 436-442.
-
(1993)
Kidney Int
, vol.43
, pp. 436-442
-
-
Sherrard, D.J.1
Hercz, G.2
Pei, Y.3
-
10
-
-
0029036314
-
Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH
-
Torres A, Lorenzo V, Hernández D y cols. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 1995; 47: 1434-1442.
-
(1995)
Kidney Int
, vol.47
, pp. 1434-1442
-
-
Torres, A.1
Lorenzo, V.2
Hernández, D.3
-
11
-
-
0032983878
-
Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: A hypothesis to integrate a historical and modern perspective
-
Felsenfeld AJ, Rodríguez M. Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: a hypothesis to integrate a historical and modern perspective. J Am Soc Nephrol 1999; 10: 878-890.
-
(1999)
J Am Soc Nephrol
, vol.10
, pp. 878-890
-
-
Felsenfeld, A.J.1
Rodríguez, M.2
-
12
-
-
20544431807
-
Calcium, phosphorus and vitamin Ddisordersin uremia
-
Slatopolsky E, Brown A, Dusso A. Calcium, phosphorus and vitamin Ddisordersin uremia. Contrib Nephrol 2005; 149: 261-271.
-
(2005)
Contrib Nephrol
, vol.149
, pp. 261-271
-
-
Slatopolsky, E.1
Brown, A.2
Dusso, A.3
-
13
-
-
34247844331
-
The Calcimimetic R-568 increases vitamin D receptor expression In rat parathyroid glands
-
Rodriguez M, Almadén Y, Canadillas S y cols. The Calcimimetic R-568 increases vitamin D receptor expression In rat parathyroid glands. Am J Physiol Renal Physiol 2007.
-
(2007)
Am J Physiol Renal Physiol
-
-
Rodriguez, M.1
Almadén, Y.2
Canadillas, S.3
-
14
-
-
85133388134
-
-
Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8-28.
-
Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8-28.
-
-
-
-
15
-
-
0025005903
-
Renal bone disease 1990: An unmet challenge for the nephrologist
-
Malluche H, Faugere MC. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990; 38: 193-211.
-
(1990)
Kidney Int
, vol.38
, pp. 193-211
-
-
Malluche, H.1
Faugere, M.C.2
-
16
-
-
0027485515
-
Aplastic osteodystrophy without aluminum: The role of suppressed parathyroid function
-
Hercz G, Pei Y, Greenwood C y cols. Aplastic osteodystrophy without aluminum: the role of «suppressed» parathyroid function. Kidney/nf 1993; 44: 860-866.
-
(1993)
Kidney/nf
, vol.44
, pp. 860-866
-
-
Hercz, G.1
Pei, Y.2
Greenwood, C.3
-
17
-
-
0035003729
-
Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients
-
Lorenzo V, Martin M, Rufino M y cols. Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis 2002; 37:1260-1266.
-
(2002)
Am J Kidney Dis
, vol.37
, pp. 1260-1266
-
-
Lorenzo, V.1
Martin, M.2
Rufino, M.3
-
18
-
-
0029059351
-
The contribution of acidosis to renal osteodystrophy
-
Bushinsky DA. The contribution of acidosis to renal osteodystrophy. Kidney Int 1995; 47: 1816-1832.
-
(1995)
Kidney Int
, vol.47
, pp. 1816-1832
-
-
Bushinsky, D.A.1
-
19
-
-
4644323860
-
Vascular calcification: A stiff challenge for the nephrologist: does preventing bone disease cause arterial disease?
-
Goldsmith D, Ritz E, Covic A. Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 2004; 66: 1315-1333.
-
(2004)
Kidney Int
, vol.66
, pp. 1315-1333
-
-
Goldsmith, D.1
Ritz, E.2
Covic, A.3
-
20
-
-
0034682247
-
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
-
Goodman WG, Goldin J, Kuizon BD y cols. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
-
(2000)
N Engl J Med
, vol.342
, pp. 1478-1483
-
-
Goodman, W.G.1
Goldin, J.2
Kuizon, B.D.3
-
21
-
-
0041318888
-
Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function
-
London GM. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol 2003; 14: S305-S309.
-
(2003)
J Am Soc Nephrol
, vol.14
-
-
London, G.M.1
-
22
-
-
0030967042
-
Atherosclerosis and arteriosclerosis in chronic renal failure
-
London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997; 51: 1678-1695.
-
(1997)
Kidney Int
, vol.51
, pp. 1678-1695
-
-
London, G.M.1
Drueke, T.B.2
-
23
-
-
0036560596
-
Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment
-
Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002; 15: 172-186.
-
(2002)
Semin Dial
, vol.15
, pp. 172-186
-
-
Wilmer, W.A.1
Magro, C.M.2
-
24
-
-
0037337818
-
Uremia Induces the osteoblast differentiation factor Cbfa1 in human blood vessels
-
Moe SM, Duan D, Doehle BP y cols. Uremia Induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003; 63: 1003-1011.
-
(2003)
Kidney Int
, vol.63
, pp. 1003-1011
-
-
Moe, S.M.1
Duan, D.2
Doehle, B.P.3
-
25
-
-
0036151662
-
Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins
-
Moe SM, O'Neill KD, Duan D y cols. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002; 61: 638-647.
-
(2002)
Kidney Int
, vol.61
, pp. 638-647
-
-
Moe, S.M.1
O'Neill, K.D.2
Duan, D.3
-
27
-
-
9644276844
-
Vascular calcification mechanisms
-
Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15:2959-2964.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2959-2964
-
-
Giachelli, C.M.1
-
29
-
-
0033634633
-
Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification
-
Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000; 3: 433-438.
-
(2000)
Curr Opin Clin Nutr Metab Care
, vol.3
, pp. 433-438
-
-
Shearer, M.J.1
-
31
-
-
0032079445
-
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
-
Bucay N, Sarosi I, Dunstan CR y cols. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268.
-
(1998)
Genes Dev
, vol.12
, pp. 1260-1268
-
-
Bucay, N.1
Sarosi, I.2
Dunstan, C.R.3
-
32
-
-
33645269267
-
Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification
-
Reynolds JL, Skepper JN, McNair R y cols. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. JAm Soc Nep 2005; 16: 2920-2930.
-
(2005)
JAm Soc Nep
, vol.16
, pp. 2920-2930
-
-
Reynolds, J.L.1
Skepper, J.N.2
McNair, R.3
-
33
-
-
0037426081
-
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study
-
Ketteler M, Bongartz P, Westenfeld R y cols. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833,.
-
(2003)
Lancet
, vol.361
, pp. 827-833
-
-
Ketteler, M.1
Bongartz, P.2
Westenfeld, R.3
-
34
-
-
0043037220
-
Vascular calcification: In vitro evidence for the role of inorganic phosphate
-
Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 14: S300-S304.
-
(2003)
J Am Soc Nephrol
, vol.14
-
-
Giachelli, C.M.1
-
35
-
-
0034730291
-
Murry CEy cols. Phosphate regulation of vascular smooth muscle cell calcification
-
Jono S, McKee MD, Murry CEy cols. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17.
-
(2000)
Circ Res
, vol.87
-
-
Jono, S.1
McKee, M.D.2
-
36
-
-
14544283020
-
Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD
-
Reynolds JL, Joannides AJ, Skepper JN y cols. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2857-2867
-
-
Reynolds, J.L.1
Joannides, A.J.2
Skepper, J.N.3
-
37
-
-
33845274560
-
Vascular calcifications: Pathogenesis, management, and impact on clinical outcomes
-
Cannata-Andia JB, Rodríguez-García M, Carrillo-López N y cols. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 2006; 17: S267-S273.
-
(2006)
J Am Soc Nephrol
, vol.17
-
-
Cannata-Andia, J.B.1
Rodríguez-García, M.2
Carrillo-López, N.3
-
38
-
-
0032578442
-
1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide
-
Jono S, Nishizawa Y, Shiol A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 1998; 98: 1302-1306.
-
(1998)
Circulation
, vol.98
, pp. 1302-1306
-
-
Jono, S.1
Nishizawa, Y.2
Shiol, A.3
Morii, H.4
-
39
-
-
33750576187
-
Mortality risk among hemodialysis patients receiving different vitamin D analogs
-
Tentori F, Hunt WC, Stidley CA y cols. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865.
-
(2006)
Kidney Int
, vol.70
, pp. 1858-1865
-
-
Tentori, F.1
Hunt, W.C.2
Stidley, C.A.3
-
40
-
-
0042343804
-
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
-
Teng M, Wolf M, Lowrie E y cols. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-456.
-
(2003)
N Engl J Med
, vol.349
, pp. 446-456
-
-
Teng, M.1
Wolf, M.2
Lowrie, E.3
-
41
-
-
33947116127
-
Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology
-
Jindal K, Chan CT, Deziel C y cols. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006; 17: S1-27.
-
(2006)
J Am Soc Nephrol
, vol.17
-
-
Jindal, K.1
Chan, C.T.2
Deziel, C.3
-
42
-
-
1542287579
-
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy
-
Martin KJ, Olgaard K, Coburn JW y cols. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004; 43: 558-565.
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 558-565
-
-
Martin, K.J.1
Olgaard, K.2
Coburn, J.W.3
-
43
-
-
83055172414
-
-
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-201.
-
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-201.
-
-
-
-
44
-
-
0141633573
-
Blood calcium, phosphorus, and magnesium
-
PA, Lippincott, Williams &Wilkins
-
Portale, A. Blood calcium, phosphorus, and magnesium. En: Favus, M. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, PA, Lippincott, Williams &Wilkins 1999; 115-118.
-
(1999)
Favus, M. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
, pp. 115-118
-
-
Portale, A.1
-
45
-
-
0027496973
-
Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease
-
Hutchison AJ, Whitehouse RW, Boulton HF y cols. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071-1077.
-
(1993)
Kidney Int
, vol.44
, pp. 1071-1077
-
-
Hutchison, A.J.1
Whitehouse, R.W.2
Boulton, H.F.3
-
46
-
-
33746125352
-
Inter-method variability in PTH measurement: Implication for the care of CKD patients
-
Souberbielle JC, Boutten A, Carlier MC y cols. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006; 350.
-
(2006)
Kidney Int
, pp. 350
-
-
Souberbielle, J.C.1
Boutten, A.2
Carlier, M.C.3
-
47
-
-
0033786216
-
Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites
-
Schomig M, Ritz E. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant 2000; 15: 18-24,.
-
(2000)
Nephrol Dial Transplant
, vol.15
, pp. 18-24
-
-
Schomig, M.1
Ritz, E.2
-
48
-
-
0037850084
-
Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levels
-
Gómez-Alonso C, Naves-Díaz ML, Fernández- Martín JL y cols. Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 2003; Supl. 44-S48.
-
(2003)
Kidney Int
, Issue.SUPL. 44-S48
-
-
Gómez-Alonso, C.1
Naves-Díaz, M.L.2
Fernández- Martín, J.L.3
-
49
-
-
0242270888
-
Bone mineral density, biochemical markers and skeletal fractures In haemodialysis patients
-
Urena P, Bernard-Poenaru O, Ostertag A y cols. Bone mineral density, biochemical markers and skeletal fractures In haemodialysis patients. Nephrol Dial Transplant 2003; 18: 2325-2331.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 2325-2331
-
-
Urena, P.1
Bernard-Poenaru, O.2
Ostertag, A.3
-
52
-
-
0029780445
-
Trends in renal osteodystrophy: A survey from 1983 to 1995 In a total of 2.248 patients
-
Monier-Faugere MC, Malluche HH. Trends in renal osteodystrophy: a survey from 1983 to 1995 In a total of 2.248 patients. Nephrol Dial Transplant 1996; 11 Supl. 3: 111 -120.
-
(1996)
Nephrol Dial Transplant
, vol.11
, Issue.SUPL. 3
, pp. 111-120
-
-
Monier-Faugere, M.C.1
Malluche, H.H.2
-
53
-
-
2942724370
-
A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients
-
Adragao T, Pires A, Lucas C y cols. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1480-1488.
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 1480-1488
-
-
Adragao, T.1
Pires, A.2
Lucas, C.3
-
54
-
-
0003171680
-
Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation
-
Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation.Am J Kidney Dis 2000; 35: S1-140.
-
(2000)
Am J Kidney Dis
, vol.35
-
-
-
55
-
-
6844251607
-
Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?
-
Rufino M, De BE, Martín M y cols. Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant 1998; 13 Supl. 3: 65-67.
-
(1998)
Nephrol Dial Transplant
, vol.13
, Issue.SUPL. 3
, pp. 65-67
-
-
Rufino, M.1
De, B.E.2
Martín, M.3
-
56
-
-
51349088036
-
Tratamiento Conservador de la Insuficiencia Renal Crónica. Hernando, L
-
Editorial Panamericana, Madrid
-
Lorenzo V, Torres A. Tratamiento Conservador de la Insuficiencia Renal Crónica. Hernando, L. 1997. Nefrología Clínica. Editorial Panamericana, Madrid.
-
(1997)
Nefrología Clínica
-
-
Lorenzo, V.1
Torres, A.2
-
57
-
-
4344638044
-
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure
-
Emmett M. A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Kidney Int 2004; Supl. S25-S32.
-
(2004)
Kidney Int
, Issue.SUPL.
-
-
Emmett, M.1
|